Euroopa Liit - islandi - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sonidegib tvífosfat - krabbamein, basalfrumur - Æxlishemjandi lyf - odomzo er ætlað til meðferðar hjá fullorðnum sjúklingum með staðbundið langt gengið grunnfrumukrabbamein (bcc) sem ekki er hægt að lækna með skurðaðgerð eða geislameðferð.

Euroopa Liit - islandi - EMA (European Medicines Agency)

novartis europharm limited - nateglinide - sykursýki, tegund 2 - lyf notuð við sykursýki - nateglinid er ætlað til samsettrar meðferðar með metformíni hjá sjúklingum með sykursýki af tegund 2 sem eru ófullnægjandi þrátt fyrir hámarksþolinn skammt af metformíni einu sér.

Euroopa Liit - islandi - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - Önnur lyf í taugakerfinu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Euroopa Liit - islandi - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - Önnur lyf í taugakerfinu - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

abcur ab - thiopentalum natricum inn - stungulyfsstofn, lausn - 1 g

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - acidum alendronicum natríum - tafla - 70 mg

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - acidum alendronicum natríum - tafla - 70 mg

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - dorzolamidum hýdróklóríð - augndropar, lausn - 20 mg/ml